Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Longitude Capital is a venture growth investment firm founded in 2006, with offices in Menlo Park, California, and Boston, Massachusetts. The firm specializes in investing in transformative healthcare companies, particularly in the biotechnology, medical technology, and health solutions sectors. With over $2 billion raised across six funds, Longitude Capital has established a strong reputation in the venture capital landscape. The firm has a proven track record of sourcing, managing, and exiting investments across various market cycles, demonstrating its resilience and adaptability in the ever-evolving healthcare market.
Longitude Capital's leadership team comprises seasoned professionals with extensive experience in healthcare investing, providing the firm with a unique perspective on market trends and opportunities. Their investment strategy is characterized by a balanced portfolio approach, focusing on both clinical-stage and commercial-stage companies that possess clinically de-risked assets. This strategic focus allows Longitude Capital to mitigate risks while maximizing potential returns for its investors.
Longitude Capital invests primarily in the healthcare sector, targeting both privately held and publicly traded companies. The firm’s investment focus encompasses a wide range of sectors within healthcare, including biotechnology, medical technology, and health solutions. Longitude Capital employs a diverse array of investment structures, which include traditional venture capital, asset spin-outs, recapitalizations, PIPEs (Private Investment in Public Equity), open market purchases, royalties, and other equity and equity-linked instruments. This flexibility in investment strategy enables the firm to adapt to the specific needs of each company and the dynamics of the market.
The firm is particularly interested in companies that are at various stages of development, from pre-seed to growth equity, allowing them to engage with startups early in their journey and support them through to commercialization. Longitude Capital seeks to invest in companies with clinically de-risked assets, which are essential for reducing investment risk and enhancing the likelihood of successful outcomes. Their focus on transformative healthcare innovations positions them as a key player in the venture capital ecosystem, particularly for startups aiming to make significant impacts in the healthcare industry.
Longitude Capital has built a diverse portfolio of 15 companies, showcasing its commitment to transformative healthcare innovations. Notable investments include Bolt Medical, which was acquired by Boston Scientific, highlighting the firm's ability to identify and support companies with high growth potential. Other significant portfolio companies include Ceribell, Endogenex, Nalu Medical, RxSight, Sydnexis, BioAge Labs, CuraSen Therapeutics, Endeavor Biomedicines, Epirium Bio, Jazz Pharmaceuticals, Opna Bio, Orbus Therapeutics, Vera Therapeutics, Veradermics, and Zenas BioPharma. These companies represent a broad spectrum of healthcare solutions, from cutting-edge biotechnology to innovative medical technologies.
The firm’s strategic investments have not only contributed to the growth of these companies but have also resulted in successful exits, underscoring Longitude Capital's expertise in navigating the complexities of the healthcare market. The firm’s focus on both clinical-stage and commercial-stage companies allows it to leverage its extensive network and industry knowledge to foster growth and drive value creation across its portfolio.
To pitch Longitude Capital, founders should visit their website at longitudecapital.com. They accept both warm introductions and cold applications, and it is important to present a clear and compelling business case that aligns with their investment focus in healthcare.
Longitude Capital invests across multiple stages, including pre-seed, seed, Series A, Series B, and growth equity. This diverse stage focus allows them to engage with companies at various points in their development journey.
Founders interested in pitching to Longitude Capital can do so through their website at longitudecapital.com. They welcome pitches from both warm introductions and cold applications, emphasizing the importance of a clear and compelling business case.
Longitude Capital primarily focuses on the healthcare sector, with a particular emphasis on biotechnology, medical technology, and health solutions. They seek transformative companies that are poised to make significant impacts in these areas.
While specific check sizes are not disclosed, Longitude Capital's fund size of $200 million suggests they are capable of making substantial investments across various stages of company development.
Longitude Capital focuses its investments primarily in North America, leveraging its deep understanding of the regional healthcare landscape to identify promising opportunities.
Longitude Capital offers extensive support to its portfolio companies, leveraging its network and expertise in the healthcare sector to assist with strategic guidance, operational improvements, and access to additional resources.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.